| 1 | | - | <tr><td class="xsl" colspan="3"><p> </p> </td></tr></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB2462 Engrossed</td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 08649 BDA 18702 b</td></tr></table></td></tr><tr><td class="xsl"> </td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code> </code><code>AN ACT concerning health.</code> </td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code> </code><b><code>Be it enacted by the People of the State of Illinois, </code></b></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><b><code>represented in the General Assembly:</code></b> </td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code> </code><code>Section 5. </code><code>The Epinephrine Injector Act is amended by </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>changing Sections 5, 10, 15, and 20 and by adding Section 25 as </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>follows:</code> </td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code> </code><code>(410 ILCS 27/5)</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code> </code><code>Sec. 5. </code><code>Definitions. </code><code>As used in this Act:</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code> </code><code>"Administer" means to directly apply an epinephrine </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><u><code>delivery system</code></u><code> </code><strike><code>injector</code></strike><code> to the body of an individual.</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code> </code><code>"Authorized entity" means any entity or organization, </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>other than a school covered under Section 22-30 of the School </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>Code, in connection with or at which allergens capable of </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>causing anaphylaxis may be present, including, but not limited </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>to, independent contractors who provide student transportation </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>to schools, recreation camps, colleges and universities, day </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>care facilities, youth sports leagues, amusement parks, </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>restaurants, sports arenas, and places of employment. The </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>Department shall, by rule, determine what constitutes a day </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>care facility under this definition.</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code> </code><u><code>"Authorized individual" means an individual who has </code></u></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><u><code>successfully completed the training program under Section 10 </code></u></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><u><code>of this Act.</code></u><code> </code></td></tr></table><table class="xsl" width="650"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB2462 Engrossed</td><td class="xsl" align="center">- 2 -</td><td class="xsl" align="right">LRB104 08649 BDA 18702 b</td></tr></table></td></tr><tr><td class="xsl"> </td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code> </code><code>"Department" means the Department of Public Health.</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code> </code><u><code>"Epinephrine delivery system" means any form of </code></u></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><u><code>epinephrine that is approved by the United States Food and </code></u></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><u><code>Drug Administration, including any device that contains a dose </code></u></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><u><code>of epinephrine, and that is used to administer epinephrine </code></u></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><u><code>into the human body to prevent or treat a life-threatening </code></u></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><u><code>allergic reaction.</code></u><code> </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code> </code><strike><code>"Epinephrine injector" includes an auto-injector approved </code></strike></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><strike><code>by the United States Food and Drug Administration for the </code></strike></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><strike><code>administration of epinephrine and a pre-filled syringe </code></strike></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><strike><code>approved by the United States Food and Drug Administration and </code></strike></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><strike><code>used for the administration of epinephrine that contains a </code></strike></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><strike><code>pre-measured dose of epinephrine that is equivalent to the </code></strike></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><strike><code>dosages used in an auto-injector.</code></strike><code> </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code> </code><code>"Health care practitioner" means a physician licensed to </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>practice medicine in all its branches under the Medical </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>Practice Act of 1987, a physician assistant under the </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>Physician Assistant Practice Act of 1987 with prescriptive </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>authority, or an advanced practice registered nurse with </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>prescribing authority under Article 65 of the Nurse Practice </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>Act.</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code> </code><code>"Pharmacist" has the meaning given to that term under </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>subsection (k-5) of Section 3 of the Pharmacy Practice Act.</code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code> </code><code>"Undesignated epinephrine injector" means an epinephrine </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>injector prescribed in the name of an authorized entity.</code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 99-711, eff. 1-1-17; 100-513, eff. 1-1-18; </code></td></tr></table><table class="xsl" width="650"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB2462 Engrossed</td><td class="xsl" align="center">- 3 -</td><td class="xsl" align="right">LRB104 08649 BDA 18702 b</td></tr></table></td></tr><tr><td class="xsl"> </td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>100-799, eff. 1-1-19</code><code>.)</code> </td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code> </code><code>(410 ILCS 27/10)</code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code> </code><code>Sec. 10. </code><code>Prescription to authorized entity; use; training.</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code> </code><code>(a) A health care practitioner may prescribe epinephrine </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>injectors in the name of an authorized entity </code><u><code>or authorized </code></u></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><u><code>individual</code></u><code> for use in accordance with this Act, and </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>pharmacists and health care practitioners may dispense </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>epinephrine </code><u><code>delivery systems</code></u><code> </code><strike><code>injectors</code></strike><code> pursuant to a </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>prescription issued in the name of an authorized entity </code><u><code>or </code></u></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><u><code>authorized individual</code></u><code>. Such prescriptions shall be valid for a </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>period of 2 years.</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code> </code><u><code>(a-1) A health care provider with prescribing authority </code></u></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><u><code>who is employed by or under contract with the Department may </code></u></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><u><code>issue a statewide standing order for the dispensing of </code></u></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><u><code>epinephrine delivery systems for use under subsection (c) by </code></u></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><u><code>authorized individuals or by employees or agents of authorized </code></u></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><u><code>entities who have completed the training required by </code></u></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><u><code>subsection (d).</code></u><code> </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code> </code><code>(b) An authorized entity </code><u><code>or authorized individual</code></u><code> may </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>acquire and stock a supply of undesignated epinephrine </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><u><code>delivery systems</code></u><code> </code><strike><code>injectors</code></strike><code> pursuant to a prescription issued </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>under subsection (a) of this Section. Such undesignated </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>epinephrine </code><u><code>delivery systems</code></u><code> </code><strike><code>injectors</code></strike><code> shall be stored in a </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>location readily accessible in an emergency and in accordance </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>with the instructions for use of the epinephrine </code><u><code>delivery </code></u></td></tr></table><table class="xsl" width="650"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB2462 Engrossed</td><td class="xsl" align="center">- 4 -</td><td class="xsl" align="right">LRB104 08649 BDA 18702 b</td></tr></table></td></tr><tr><td class="xsl"> </td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><u><code>systems</code></u><code> </code><strike><code>injectors</code></strike><code>. The Department may establish any additional </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>requirements an authorized entity </code><u><code>or authorized individual</code></u><code> </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>must follow under this Act.</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code> </code><code>(c) An employee or agent of an authorized entity </code><u><code>who is an </code></u></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><u><code>authorized individual</code></u><code> or </code><u><code>any</code></u><code> other individual who </code><u><code>is an </code></u></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><u><code>authorized individual</code></u><code> </code><strike><code>has completed training under subsection </code></strike></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><strike><code>(d) of this Section</code></strike><code> may:</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code> </code><code> </code><code>(1) </code><u><code>anywhere allergens capable of causing anaphylaxis </code></u></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" > <u><code>may be present</code></u><code> provide an epinephrine </code><u><code>delivery system</code></u><code> </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" > <strike><code>injector</code></strike><code> to any individual </code><strike><code>on the property of the </code></strike></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" > <strike><code>authorized entity</code></strike><code> whom the employee, agent, or other </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" > <code>individual believes in good faith is experiencing </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" > <code>anaphylaxis, or to the parent, guardian, or caregiver of </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" > <code>such individual, for immediate administration, regardless </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" > <code>of whether the individual has a prescription for an </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" > <code>epinephrine </code><u><code>delivery system</code></u><code> </code><strike><code>injector</code></strike><code> or has previously </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" > <code>been diagnosed with an allergy; or</code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code> </code><code> </code><code>(2) </code><u><code>anywhere allergens capable of causing anaphylaxis </code></u></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" > <u><code>may be present</code></u><code> administer an epinephrine </code><u><code>delivery system</code></u><code> </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" > <strike><code>injector</code></strike><code> to any individual </code><strike><code>on the property of the </code></strike></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" > <strike><code>authorized entity</code></strike><code> whom the employee, agent, or other </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" > <code>individual believes in good faith is experiencing </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" > <code>anaphylaxis, regardless of whether the individual has a </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" > <code>prescription for an epinephrine </code><u><code>delivery system</code></u><code> </code><strike><code>injector</code></strike><code> </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" > <code>or has previously been diagnosed with an allergy.</code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code> </code><code>(d) An employee, agent, or other individual authorized </code></td></tr></table><table class="xsl" width="650"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB2462 Engrossed</td><td class="xsl" align="center">- 5 -</td><td class="xsl" align="right">LRB104 08649 BDA 18702 b</td></tr></table></td></tr><tr><td class="xsl"> </td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>must complete an anaphylaxis training program before he or she </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>is able to provide or administer an epinephrine </code><u><code>delivery </code></u></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><u><code>system</code></u><code> </code><strike><code>injector</code></strike><code> under this Section. Such training shall be </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>valid for a period of 2 years and shall be conducted by a </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>nationally recognized organization experienced in training </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>laypersons in emergency health treatment. The Department shall </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>include links to training providers' websites on its website.</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code> </code><code>Training shall include, but is not limited to:</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code> </code><code> </code><code>(1) how to recognize signs and symptoms of an allergic </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" > <code>reaction, including anaphylaxis;</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code> </code><code> </code><code>(2) how to administer an epinephrine </code><u><code>delivery system</code></u><code> </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" > <strike><code>injector</code></strike><code>; and</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code> </code><code> </code><code>(3) a test demonstrating competency of the knowledge </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" > <code>required to recognize anaphylaxis and administer an </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" > <code>epinephrine </code><u><code>delivery system</code></u><code> </code><strike><code>injector</code></strike><code>.</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code> </code><code>Training may also include, but is not limited to:</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code> </code><code> </code><code>(A) a review of high-risk areas on the authorized </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" > <code>entity's property and its related facilities;</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code> </code><code> </code><code>(B) steps to take to prevent exposure to allergens;</code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code> </code><code> </code><code>(C) emergency follow-up procedures; and</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code> </code><code> </code><code>(D) other criteria as determined in rules adopted </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" > <code>pursuant to this Act.</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code> </code><code>Training may be conducted either online or in person. </code><u><code>The </code></u></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><u><code>entity or individual conducting the training shall issue a </code></u></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><u><code>certificate to each person who successfully completes the </code></u></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><u><code>anaphylaxis training program.</code></u><code> The Department shall approve </code></td></tr></table><table class="xsl" width="650"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB2462 Engrossed</td><td class="xsl" align="center">- 6 -</td><td class="xsl" align="right">LRB104 08649 BDA 18702 b</td></tr></table></td></tr><tr><td class="xsl"> </td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>training programs and list permitted training programs on the </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>Department's Internet website.</code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 99-711, eff. 1-1-17; 100-799, eff. 1-1-19</code><code>.)</code> </td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code> </code><code>(410 ILCS 27/15)</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code> </code><code>Sec. 15. </code><code>Costs. </code><code>Whichever entity initiates the process of </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>obtaining undesignated epinephrine </code><u><code>delivery systems</code></u><code> </code><strike><code>injectors</code></strike><code> </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>and providing training to personnel for carrying and </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>administering undesignated epinephrine </code><u><code>delivery systems</code></u><code> </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><strike><code>injectors</code></strike><code> shall pay for the costs of the undesignated </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>epinephrine </code><u><code>delivery systems</code></u><code> </code><strike><code>injectors</code></strike><code>.</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 99-711, eff. 1-1-17; 100-799, eff. 1-1-19</code><code>.)</code> </td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code> </code><code>(410 ILCS 27/20)</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code> </code><code>Sec. 20. </code><code>Limitations. </code><code>The use of an undesignated </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>epinephrine </code><u><code>delivery system</code></u><code> </code><strike><code>injector</code></strike><code> in accordance with the </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>requirements of this Act does not constitute the practice of </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>medicine or any other profession that requires medical </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>licensure.</code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code> </code><code>Nothing in this Act shall limit the amount of epinephrine </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><u><code>delivery systems</code></u><code> </code><strike><code>injectors</code></strike><code> that an authorized entity or </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>individual may carry or maintain a supply of.</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 99-711, eff. 1-1-17; 100-799, eff. 1-1-19</code><code>.)</code> </td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code> </code><code>(410 ILCS 27/25 new)</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code> </code><u><code>Sec. 25. </code></u><u><code>Liability limitation. </code></u><u><code>An authorized individual </code></u></td></tr></table><table class="xsl" width="650"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB2462 Engrossed</td><td class="xsl" align="center">- 7 -</td><td class="xsl" align="right">LRB104 08649 BDA 18702 b</td></tr></table></td></tr><tr><td class="xsl"> </td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><u><code>who acts in good faith to provide or administer an epinephrine </code></u></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><u><code>delivery system in an emergency situation pursuant to this </code></u></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><u><code>Act, shall not, as a result of the authorized individual's </code></u></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><u><code>acts, except for willful and wanton misconduct on the part of </code></u></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><u><code>that individual, be liable for civil damages to a person to </code></u></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><u><code>whom such epinephrine delivery system was given to or </code></u></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><u><code>administered. This limitation of liability applies only to the </code></u></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><u><code>act of providing or administering the epinephrine delivery </code></u></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><u><code>system and shall not extend to any other care or treatment </code></u></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><u><code>provided at or around the time of the epinephrine delivery </code></u></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><u><code>system administration.</code></u> |
|---|
| 1 | + | 104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 HB2462 Introduced , by Rep. Maurice A. West, II SYNOPSIS AS INTRODUCED: 410 ILCS 27/5410 ILCS 27/10410 ILCS 27/25 new745 ILCS 49/66 new Amends the Epinephrine Injector Act. Defines "authorized individual". Adds references to "authorized individual" in provisions regarding those persons who may provide or administer an epinephrine injector. Requires the issuance of a certificate upon completion of an anaphylaxis training program. Adds provisions regarding good Samaritan protections. Amends the Good Samaritan Act. Limits the liability of authorized individuals who may provide or administer an epinephrine injector. LRB104 08649 BDA 18702 b A BILL FOR 104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 HB2462 Introduced , by Rep. Maurice A. West, II SYNOPSIS AS INTRODUCED: 410 ILCS 27/5410 ILCS 27/10410 ILCS 27/25 new745 ILCS 49/66 new 410 ILCS 27/5 410 ILCS 27/10 410 ILCS 27/25 new 745 ILCS 49/66 new Amends the Epinephrine Injector Act. Defines "authorized individual". Adds references to "authorized individual" in provisions regarding those persons who may provide or administer an epinephrine injector. Requires the issuance of a certificate upon completion of an anaphylaxis training program. Adds provisions regarding good Samaritan protections. Amends the Good Samaritan Act. Limits the liability of authorized individuals who may provide or administer an epinephrine injector. LRB104 08649 BDA 18702 b LRB104 08649 BDA 18702 b A BILL FOR |
|---|
| 2 | + | 104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 HB2462 Introduced , by Rep. Maurice A. West, II SYNOPSIS AS INTRODUCED: |
|---|
| 3 | + | 410 ILCS 27/5410 ILCS 27/10410 ILCS 27/25 new745 ILCS 49/66 new 410 ILCS 27/5 410 ILCS 27/10 410 ILCS 27/25 new 745 ILCS 49/66 new |
|---|
| 4 | + | 410 ILCS 27/5 |
|---|
| 5 | + | 410 ILCS 27/10 |
|---|
| 6 | + | 410 ILCS 27/25 new |
|---|
| 7 | + | 745 ILCS 49/66 new |
|---|
| 8 | + | Amends the Epinephrine Injector Act. Defines "authorized individual". Adds references to "authorized individual" in provisions regarding those persons who may provide or administer an epinephrine injector. Requires the issuance of a certificate upon completion of an anaphylaxis training program. Adds provisions regarding good Samaritan protections. Amends the Good Samaritan Act. Limits the liability of authorized individuals who may provide or administer an epinephrine injector. |
|---|
| 9 | + | LRB104 08649 BDA 18702 b LRB104 08649 BDA 18702 b |
|---|
| 10 | + | LRB104 08649 BDA 18702 b |
|---|
| 11 | + | A BILL FOR |
|---|
| 12 | + | HB2462LRB104 08649 BDA 18702 b HB2462 LRB104 08649 BDA 18702 b |
|---|
| 13 | + | HB2462 LRB104 08649 BDA 18702 b |
|---|
| 14 | + | 1 AN ACT concerning health. |
|---|
| 15 | + | 2 Be it enacted by the People of the State of Illinois, |
|---|
| 16 | + | 3 represented in the General Assembly: |
|---|
| 17 | + | 4 Section 5. The Epinephrine Injector Act is amended by |
|---|
| 18 | + | 5 changing Sections 5 and 10 and by adding Section 25 as follows: |
|---|
| 19 | + | 6 (410 ILCS 27/5) |
|---|
| 20 | + | 7 Sec. 5. Definitions. As used in this Act: |
|---|
| 21 | + | 8 "Administer" means to directly apply an epinephrine |
|---|
| 22 | + | 9 injector to the body of an individual. |
|---|
| 23 | + | 10 "Authorized entity" means any entity or organization, |
|---|
| 24 | + | 11 other than a school covered under Section 22-30 of the School |
|---|
| 25 | + | 12 Code, in connection with or at which allergens capable of |
|---|
| 26 | + | 13 causing anaphylaxis may be present, including, but not limited |
|---|
| 27 | + | 14 to, independent contractors who provide student transportation |
|---|
| 28 | + | 15 to schools, recreation camps, colleges and universities, day |
|---|
| 29 | + | 16 care facilities, youth sports leagues, amusement parks, |
|---|
| 30 | + | 17 restaurants, sports arenas, and places of employment. The |
|---|
| 31 | + | 18 Department shall, by rule, determine what constitutes a day |
|---|
| 32 | + | 19 care facility under this definition. |
|---|
| 33 | + | 20 "Authorized individual" means an individual who has |
|---|
| 34 | + | 21 successfully completed the training program under Section 10 |
|---|
| 35 | + | 22 of this Act. |
|---|
| 36 | + | 23 "Department" means the Department of Public Health. |
|---|
| 37 | + | |
|---|
| 38 | + | |
|---|
| 39 | + | |
|---|
| 40 | + | 104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 HB2462 Introduced , by Rep. Maurice A. West, II SYNOPSIS AS INTRODUCED: |
|---|
| 41 | + | 410 ILCS 27/5410 ILCS 27/10410 ILCS 27/25 new745 ILCS 49/66 new 410 ILCS 27/5 410 ILCS 27/10 410 ILCS 27/25 new 745 ILCS 49/66 new |
|---|
| 42 | + | 410 ILCS 27/5 |
|---|
| 43 | + | 410 ILCS 27/10 |
|---|
| 44 | + | 410 ILCS 27/25 new |
|---|
| 45 | + | 745 ILCS 49/66 new |
|---|
| 46 | + | Amends the Epinephrine Injector Act. Defines "authorized individual". Adds references to "authorized individual" in provisions regarding those persons who may provide or administer an epinephrine injector. Requires the issuance of a certificate upon completion of an anaphylaxis training program. Adds provisions regarding good Samaritan protections. Amends the Good Samaritan Act. Limits the liability of authorized individuals who may provide or administer an epinephrine injector. |
|---|
| 47 | + | LRB104 08649 BDA 18702 b LRB104 08649 BDA 18702 b |
|---|
| 48 | + | LRB104 08649 BDA 18702 b |
|---|
| 49 | + | A BILL FOR |
|---|
| 50 | + | |
|---|
| 51 | + | |
|---|
| 52 | + | |
|---|
| 53 | + | |
|---|
| 54 | + | |
|---|
| 55 | + | 410 ILCS 27/5 |
|---|
| 56 | + | 410 ILCS 27/10 |
|---|
| 57 | + | 410 ILCS 27/25 new |
|---|
| 58 | + | 745 ILCS 49/66 new |
|---|
| 59 | + | |
|---|
| 60 | + | |
|---|
| 61 | + | |
|---|
| 62 | + | LRB104 08649 BDA 18702 b |
|---|
| 63 | + | |
|---|
| 64 | + | |
|---|
| 65 | + | |
|---|
| 66 | + | |
|---|
| 67 | + | |
|---|
| 68 | + | |
|---|
| 69 | + | |
|---|
| 70 | + | |
|---|
| 71 | + | |
|---|
| 72 | + | HB2462 LRB104 08649 BDA 18702 b |
|---|
| 73 | + | |
|---|
| 74 | + | |
|---|
| 75 | + | HB2462- 2 -LRB104 08649 BDA 18702 b HB2462 - 2 - LRB104 08649 BDA 18702 b |
|---|
| 76 | + | HB2462 - 2 - LRB104 08649 BDA 18702 b |
|---|
| 77 | + | 1 "Epinephrine injector" includes an auto-injector approved |
|---|
| 78 | + | 2 by the United States Food and Drug Administration for the |
|---|
| 79 | + | 3 administration of epinephrine and a pre-filled syringe |
|---|
| 80 | + | 4 approved by the United States Food and Drug Administration and |
|---|
| 81 | + | 5 used for the administration of epinephrine that contains a |
|---|
| 82 | + | 6 pre-measured dose of epinephrine that is equivalent to the |
|---|
| 83 | + | 7 dosages used in an auto-injector. |
|---|
| 84 | + | 8 "Health care practitioner" means a physician licensed to |
|---|
| 85 | + | 9 practice medicine in all its branches under the Medical |
|---|
| 86 | + | 10 Practice Act of 1987, a physician assistant under the |
|---|
| 87 | + | 11 Physician Assistant Practice Act of 1987 with prescriptive |
|---|
| 88 | + | 12 authority, or an advanced practice registered nurse with |
|---|
| 89 | + | 13 prescribing authority under Article 65 of the Nurse Practice |
|---|
| 90 | + | 14 Act. |
|---|
| 91 | + | 15 "Pharmacist" has the meaning given to that term under |
|---|
| 92 | + | 16 subsection (k-5) of Section 3 of the Pharmacy Practice Act. |
|---|
| 93 | + | 17 "Undesignated epinephrine injector" means an epinephrine |
|---|
| 94 | + | 18 injector prescribed in the name of an authorized entity. |
|---|
| 95 | + | 19 (Source: P.A. 99-711, eff. 1-1-17; 100-513, eff. 1-1-18; |
|---|
| 96 | + | 20 100-799, eff. 1-1-19.) |
|---|
| 97 | + | 21 (410 ILCS 27/10) |
|---|
| 98 | + | 22 Sec. 10. Prescription to authorized entity; use; training. |
|---|
| 99 | + | 23 (a) A health care practitioner may prescribe epinephrine |
|---|
| 100 | + | 24 injectors in the name of an authorized entity for use in |
|---|
| 101 | + | 25 accordance with this Act, and pharmacists and health care |
|---|
| 102 | + | |
|---|
| 103 | + | |
|---|
| 104 | + | |
|---|
| 105 | + | |
|---|
| 106 | + | |
|---|
| 107 | + | HB2462 - 2 - LRB104 08649 BDA 18702 b |
|---|
| 108 | + | |
|---|
| 109 | + | |
|---|
| 110 | + | HB2462- 3 -LRB104 08649 BDA 18702 b HB2462 - 3 - LRB104 08649 BDA 18702 b |
|---|
| 111 | + | HB2462 - 3 - LRB104 08649 BDA 18702 b |
|---|
| 112 | + | 1 practitioners may dispense epinephrine injectors pursuant to a |
|---|
| 113 | + | 2 prescription issued in the name of an authorized entity. Such |
|---|
| 114 | + | 3 prescriptions shall be valid for a period of 2 years. |
|---|
| 115 | + | 4 (b) An authorized entity may acquire and stock a supply of |
|---|
| 116 | + | 5 undesignated epinephrine injectors pursuant to a prescription |
|---|
| 117 | + | 6 issued under subsection (a) of this Section. Such undesignated |
|---|
| 118 | + | 7 epinephrine injectors shall be stored in a location readily |
|---|
| 119 | + | 8 accessible in an emergency and in accordance with the |
|---|
| 120 | + | 9 instructions for use of the epinephrine injectors. The |
|---|
| 121 | + | 10 Department may establish any additional requirements an |
|---|
| 122 | + | 11 authorized entity must follow under this Act. |
|---|
| 123 | + | 12 (c) An employee or agent of an authorized entity who is an |
|---|
| 124 | + | 13 authorized individual or any other other individual who is an |
|---|
| 125 | + | 14 authorized individual has completed training under subsection |
|---|
| 126 | + | 15 (d) of this Section may: |
|---|
| 127 | + | 16 (1) provide an epinephrine injector to any individual |
|---|
| 128 | + | 17 on the property of the authorized entity whom the |
|---|
| 129 | + | 18 employee, agent, or other individual believes in good |
|---|
| 130 | + | 19 faith is experiencing anaphylaxis, or to the parent, |
|---|
| 131 | + | 20 guardian, or caregiver of such individual, for immediate |
|---|
| 132 | + | 21 administration, regardless of whether the individual has a |
|---|
| 133 | + | 22 prescription for an epinephrine injector or has previously |
|---|
| 134 | + | 23 been diagnosed with an allergy; or |
|---|
| 135 | + | 24 (2) administer an epinephrine injector to any |
|---|
| 136 | + | 25 individual on the property of the authorized entity whom |
|---|
| 137 | + | 26 the employee, agent, or other individual believes in good |
|---|
| 138 | + | |
|---|
| 139 | + | |
|---|
| 140 | + | |
|---|
| 141 | + | |
|---|
| 142 | + | |
|---|
| 143 | + | HB2462 - 3 - LRB104 08649 BDA 18702 b |
|---|
| 144 | + | |
|---|
| 145 | + | |
|---|
| 146 | + | HB2462- 4 -LRB104 08649 BDA 18702 b HB2462 - 4 - LRB104 08649 BDA 18702 b |
|---|
| 147 | + | HB2462 - 4 - LRB104 08649 BDA 18702 b |
|---|
| 148 | + | 1 faith is experiencing anaphylaxis, regardless of whether |
|---|
| 149 | + | 2 the individual has a prescription for an epinephrine |
|---|
| 150 | + | 3 injector or has previously been diagnosed with an allergy. |
|---|
| 151 | + | 4 (d) An employee, agent, or other individual authorized |
|---|
| 152 | + | 5 must complete an anaphylaxis training program before he or she |
|---|
| 153 | + | 6 is able to provide or administer an epinephrine injector under |
|---|
| 154 | + | 7 this Section. Such training shall be valid for a period of 2 |
|---|
| 155 | + | 8 years and shall be conducted by a nationally recognized |
|---|
| 156 | + | 9 organization experienced in training laypersons in emergency |
|---|
| 157 | + | 10 health treatment. The Department shall include links to |
|---|
| 158 | + | 11 training providers' websites on its website. |
|---|
| 159 | + | 12 Training shall include, but is not limited to: |
|---|
| 160 | + | 13 (1) how to recognize signs and symptoms of an allergic |
|---|
| 161 | + | 14 reaction, including anaphylaxis; |
|---|
| 162 | + | 15 (2) how to administer an epinephrine injector; and |
|---|
| 163 | + | 16 (3) a test demonstrating competency of the knowledge |
|---|
| 164 | + | 17 required to recognize anaphylaxis and administer an |
|---|
| 165 | + | 18 epinephrine injector. |
|---|
| 166 | + | 19 Training may also include, but is not limited to: |
|---|
| 167 | + | 20 (A) a review of high-risk areas on the authorized |
|---|
| 168 | + | 21 entity's property and its related facilities; |
|---|
| 169 | + | 22 (B) steps to take to prevent exposure to allergens; |
|---|
| 170 | + | 23 (C) emergency follow-up procedures; and |
|---|
| 171 | + | 24 (D) other criteria as determined in rules adopted |
|---|
| 172 | + | 25 pursuant to this Act. |
|---|
| 173 | + | 26 Training may be conducted either online or in person. The |
|---|
| 174 | + | |
|---|
| 175 | + | |
|---|
| 176 | + | |
|---|
| 177 | + | |
|---|
| 178 | + | |
|---|
| 179 | + | HB2462 - 4 - LRB104 08649 BDA 18702 b |
|---|
| 180 | + | |
|---|
| 181 | + | |
|---|
| 182 | + | HB2462- 5 -LRB104 08649 BDA 18702 b HB2462 - 5 - LRB104 08649 BDA 18702 b |
|---|
| 183 | + | HB2462 - 5 - LRB104 08649 BDA 18702 b |
|---|
| 184 | + | 1 entity or individual conducting the training shall issue a |
|---|
| 185 | + | 2 certificate to each person who successfully completes the |
|---|
| 186 | + | 3 anaphylaxis training program. The Department shall approve |
|---|
| 187 | + | 4 training programs and list permitted training programs on the |
|---|
| 188 | + | 5 Department's Internet website. |
|---|
| 189 | + | 6 (Source: P.A. 99-711, eff. 1-1-17; 100-799, eff. 1-1-19.) |
|---|
| 190 | + | 7 (410 ILCS 27/25 new) |
|---|
| 191 | + | 8 Sec. 25. Good Samaritan protections. Any act or omission |
|---|
| 192 | + | 9 taken in good faith pursuant to this Act by any of the |
|---|
| 193 | + | 10 following entities or individuals shall be considered |
|---|
| 194 | + | 11 emergency care, advice, or assistance under the Good Samaritan |
|---|
| 195 | + | 12 Act: (i) an authorized entity that possesses and makes |
|---|
| 196 | + | 13 available epinephrine injectors and its employees or agents; |
|---|
| 197 | + | 14 (ii) an authorized individual who possesses, makes available, |
|---|
| 198 | + | 15 and administers epinephrine injectors; (iii) a pharmacy or |
|---|
| 199 | + | 16 manufacturer that dispenses epinephrine injectors to an |
|---|
| 200 | + | 17 authorized entity or authorized individual; or (iv) an |
|---|
| 201 | + | 18 individual or entity that conducts the training described in |
|---|
| 202 | + | 19 subsection (d) of Section 10 of this Act. |
|---|
| 203 | + | 20 Section 10. The Good Samaritan Act is amended by adding |
|---|
| 204 | + | 21 Section 66 as follows: |
|---|
| 205 | + | 22 (745 ILCS 49/66 new) |
|---|
| 206 | + | 23 Sec. 66. Provision and administration of epinephrine |
|---|
| 207 | + | |
|---|
| 208 | + | |
|---|
| 209 | + | |
|---|
| 210 | + | |
|---|
| 211 | + | |
|---|
| 212 | + | HB2462 - 5 - LRB104 08649 BDA 18702 b |
|---|
| 213 | + | |
|---|
| 214 | + | |
|---|
| 215 | + | HB2462- 6 -LRB104 08649 BDA 18702 b HB2462 - 6 - LRB104 08649 BDA 18702 b |
|---|
| 216 | + | HB2462 - 6 - LRB104 08649 BDA 18702 b |
|---|
| 217 | + | |
|---|
| 218 | + | |
|---|
| 219 | + | |
|---|
| 220 | + | |
|---|
| 221 | + | |
|---|
| 222 | + | HB2462 - 6 - LRB104 08649 BDA 18702 b |
|---|